 | | Delavirdine (Rescriptor) |  | | Published
January 25, 2001; Updated
March 2013 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-02-02 | | | Selected References | | 4. | Tran JQ, Petersen C, Garrett MK, et al. The pharmacokinetics (PK) and tolerability of indinavir (IDV) and delavirdine (DLV) administered twice-daily (BID) in the absence and presence of food in healthy volunteers. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 2000; Toronto. Abstract 1634. | |
| 5. | Blanco JL, Mallolas J, Sarasa M, et al. A pilot study of a twice-daily (BID) combination of indinavir/delavirdine plus two nucleoside analogues for salvage therapy in HIV-1 infected patients. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 2000; Toronto. Abstract 1543. | |
|
|
|
